These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 336160)

  • 1. [Relationship between cardiovascular diseases and hyperlipemia. Benefits of hypolipemic therapy].
    Daubresse JC; Luyckx A
    Brux Med; 1977 Nov; 57(11):491-7. PubMed ID: 336160
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of lipid metabolism disorders in the elderly].
    Mizera W; Grzeszczak W
    Wiad Lek; 1998; 51 Suppl 2():52-7. PubMed ID: 9686534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hyperlipidemia in human renal disease.
    D'Amico GD; Gentile MG
    Miner Electrolyte Metab; 1993; 19(3):196-204. PubMed ID: 8232107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid anomalies during renal insufficiency: consequences on the progression of renal insufficiency and cardiovascular risk].
    Moulin B
    Nephrologie; 2000; 21(7):339-41. PubMed ID: 11200605
    [No Abstract]   [Full Text] [Related]  

  • 5. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.
    Fodor JG; Frohlich JJ; Genest JJ; McPherson PR
    CMAJ; 2000 May; 162(10):1441-7. PubMed ID: 10834048
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biological exploration and basis of dietetic and pharmacological treatment for atheogenic hyperlipemia].
    de Gennes JL
    Ann Cardiol Angeiol (Paris); 1973; 22(1):33-40. PubMed ID: 4704427
    [No Abstract]   [Full Text] [Related]  

  • 7. [Is it necessary to systematically treat diabetics with statins?].
    Vergès B
    Journ Annu Diabetol Hotel Dieu; 2001; ():189-95. PubMed ID: 11565462
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipid-lowering therapy in chronic kidney disease].
    Fernández-Vega F
    Nefrologia; 2004; 24 Suppl(6):113-26, 187-235. PubMed ID: 15696902
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dyslipidemias and cardiovascular diseases: towards a new perspective].
    Darioli R; Depairon M; Perdrix J; Mooser V
    Rev Med Suisse Romande; 2002 Oct; 122(10):489-93. PubMed ID: 12494781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update.
    Genest J; Frohlich J; Fodor G; McPherson R;
    CMAJ; 2003 Oct; 169(9):921-4. PubMed ID: 14581310
    [No Abstract]   [Full Text] [Related]  

  • 11. [Controversies and advances in the treatment of hyperlipidemias].
    Reza-Albarrán A; Aguilar-Salinas CA
    Gac Med Mex; 1998; 134(2):253-6. PubMed ID: 9619005
    [No Abstract]   [Full Text] [Related]  

  • 12. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease.
    Kidney Disease Outcomes Quality Initiative (K/DOQI) Group
    Am J Kidney Dis; 2003 Apr; 41(4 Suppl 3):I-IV, S1-91. PubMed ID: 12671933
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipid lowering therapy for adults with diabetes.
    Jackowski L; Crockett J; Rowett D
    Aust Fam Physician; 2008; 37(1-2):39-41. PubMed ID: 18239751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing dyslipidaemia: current concepts.
    Schachter M
    Practitioner; 2002 Jul; 246(1636):496-9. PubMed ID: 12132267
    [No Abstract]   [Full Text] [Related]  

  • 15. Common questions in managing hyperlipidemia.
    Rosen IM; Sams RW
    Prim Care; 2006 Dec; 33(4):903-21. PubMed ID: 17169673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing drug usage and adverse effects. Part III: Cardiovascular disease and hyperlipidemia.
    Baron M
    Health Care Food Nutr Focus; 2005 Jun; 22(6):7-11. PubMed ID: 15923907
    [No Abstract]   [Full Text] [Related]  

  • 17. Dyslipidemia in diabetes. A comprehensive analysis.
    Larsen JL
    Adv Nurse Pract; 1998 Apr; 6(4):36-43. PubMed ID: 9611482
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of the efficacy of pantethine, acipimox, and bezafibrate on plasma lipids and index of cardiovascular risk in diabetics with dyslipidemia].
    Tonutti L; Taboga C; Noacco C
    Minerva Med; 1991 Oct; 82(10):657-63. PubMed ID: 1745376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation and management of dyslipidemia in HIV-infected patients.
    Fichtenbaum CJ
    AIDS Clin Care; 2001 Dec; 13(12):113-7, 120. PubMed ID: 11769116
    [No Abstract]   [Full Text] [Related]  

  • 20. [Detection and management of lipid disorders in the diabetic patient].
    Laudo Pardos C; Puigddevall Gallego V; San Martín Barrio L
    An Med Interna; 1993 Dec; 10(12):607-10. PubMed ID: 8049329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.